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The Workshop highlighted the current findings of several
centers studying the immunologic and genetic aspects of
alopecia areata (AA), including the resistance of interferon-g
(IFN-g)-knockout mice to the development of AA, and
results of an open pilot study using anti-INF-g in the
treatment of human AA.
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Alopecia areata (AA) is a suspected autoimmune disease in
which the hair follicles are targeted by CD4þ and CD8þ
lymphocytes. Although the skin is the primary location
of the clinical phenotype, the determination of disease
expression involves a complex interplay between different
inflammatory cell subsets in the skin, skin draining lymph
nodes, and spleens of affected individuals (McElwee et al,
2002). There is likely a threshold level of inflammatory cell
activation that must be reached in lymphoid organs and
additionally an intensity of inflammation around hair follicles
that activated autoaggressive cells must attain before overt
hair loss occurs (McElwee et al, 2001). This threshold level
that the autoaggressive cells must breach for autoimmune
disease to occur may be raised or lowered in part by the
size and strength of the counter response from immune
system regulatory cells.
Understanding how the immune system distinguishes
between non-self, or ‘‘danger’’ antigens, and self-, or ‘‘non-
danger’’ antigens, inhibiting autoimmune responses but
permitting an inflammatory defense against pathogens, is
a key issue in understanding why autoimmune diseases
develop (Matzinger, 2002). Whether an immune response is
against autoantigens or exogenous antigens that have
penetrated into host tissues, an unrestrained inflammatory
reaction could cause significant damage to host tissue.
There is now accumulating evidence in humans and animal
models that the normal immune system retains cell subsets
that can control inflammatory activity. These cell subsets
work to ensure that inflammatory responses against
exogenous antigens remain within manageable limits of
tissue damage and they constitute a ‘‘peripheral self-
tolerance’’ mechanism to help prevent autoreactivity. There
are several candidate regulatory cell populations involved in
peripheral self-tolerance including natural killer (NK) cell
subsets, g–d Tcells, subsets of CD8þ cells, and CD4þ cell
subsets.
The concept of specialized regulatory cells (previously
referred to as ‘‘suppressor’’ cells) in the immune system was
first suggested in the early 1970s (Gershon and Kondo,
1970). Regulatory cells were thought to be specialized
populations that mediated their effects through the secre-
tion of antigen-specific factors. But interest in regulatory
cells dissipated in the 1980s because the molecular
mechanisms involved in immunosuppression were difficult
to characterize (Green and Webb, 1993). Interest in
regulatory cells was revitalized by the description of a
marker for the identification and isolation of a CD4þ
regulatory cell subset (Sakaguchi et al, 1995). Sakaguchi
and colleagues showed that a minor population (10%) of
CD4þ T cells, which co-expresses the interleukin-2
receptor (IL-2R) a-chain (CD25), could control autoreactive
T cells in vivo. CD4þCD25þ regulatory T cells were
originally discovered in mice, but a population with identical
phenotypic and functional properties has also now been
defined in humans (Jonuleit et al, 2001). Dysfunction within
regulatory cell subsets could be a significant contributor to
autoimmune disease susceptibility.
In the C3H/HeJ mouse model for AA there is an apparent
reduction in the number and function of the candidate
CD4þ /CD25þ regulatory cell population (Zo¨ller et al,
2002). This likely lowers the threshold of activity that
autoaggressive cells must attain for overt hair loss to
develop in the affected mice. Comparative studies in
humans by flow cytometric analysis of peripheral blood
mononuclear cells have yielded a more complex picture.
Rather than a reduction in the number of CD4þ /CD25þ
cells, an increase in this cell population is observed,
particularly in the active phase of AA development. But,
in vitro assays using this cell subset have shown a relative
inability of the CD4þ /CD25þ cell population to inhibit the
proliferation of activated cells derived from patients with a
progressive state of AA (Zo¨ller et al, 2004a). Examination
of the CD4þ /CD25þ cell profile from AA patients has
revealed an inappropriately increased frequency of CD154
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expression and production of the pro-inflammatory cytokine
IL-12 in addition to the expected increased expression of
regulatory cytokine IL-10. As such, some of the CD4þ /
CD25þ cells in AA patients’ PBMC probably do not retain
true regulatory cell properties. Further research is required
to determine whether there is an effective functional
deficiency of CD4þ /CD25þ regulatory cells.
Using the mouse model, the CD4þ /CD25 cell subset
has been defined as the primary candidate pro-inflamma-
tory pathogenic cell subset with the capacity to induce AA
(McElwee et al, 2005). Examination of this cell subset in
humans with progressive AA reveals an activated state with
significantly increased expression of co-stimulatory ligands,
such as CD28, and production of pro-inflammatory cyto-
kines IL-12, IFN-g, and TNFa (Zo¨ller et al, 2004a, b). In
addition, CD4þ /CD25 cells from AA patients are relatively
resistant to apoptosis, as defined by a reduction in annexin
V binding, compared with the continued susceptibility to
apoptosis observed in CD4þ /CD25þ cells. Similar fea-
tures have been demonstrated in other autoimmune
disease mechanisms. These properties of the CD4þ /
CD25 cell population may raise the threshold of activity
that regulatory cells must attain to successfully promote
anergy or activation-induced cell death in CD4þ /CD25
cells and prevent autoimmunity. Boosting the number and
function of CD4þ /CD25þ regulatory cells and reducing
apoptosis resistance in the CD4þ /CD25 candidate
pathogenic cell population may be beneficial in the
treatment of AA. Although still very much a theoretical
option, research to develop such therapeutic approaches
for other autoimmune diseases is being conducted and
might be adapted for treating AA (Tang et al, 2004).
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Alopecia areata (AA) is a multifactorial disorder, in which
genetic and environmental factors combine to result in the
phenotype (Green and Sinclair, 2000). The prognosis of AA
is unpredictable and there is no definitive treatment. Several
lines of evidence support the polygenic inheritance of AA,
including the high prevalence of the trait, the Gaussian
curve of distribution of the phenotype, and heritability
among first-degree relatives (Aita and Christiano, 2001).
Genetic studies have been limited to association analyses,
which suggest that a permissive HLA status may potentiate
the development of AA (Welsh et al, 1994).
With the hypothesis that there is a genetic basis
underlying the susceptibility to develop AA, we initiated a
search for susceptibility genes by performing a genome-
wide scan in multiplex AA pedigrees. The genetic dissection
of complex traits has traditionally been focused on large
collections of small families (affected sib pairs, for example).
But it has recently been shown that a small sample of larger
pedigrees can potentially derive more robust results,
because of a reduced level of genetic heterogeneity
(‘‘noise’’), enrichment of genetic factors within families,
and the availability of the pedigree structure (Terwilliger and
Goring, 2000).
The ascertainment and diagnosis of the families studied
was undertaken by a dermatologist (Dr Abraham Zloto-
gorski), and using the diagnostic questionnaire developed
by the NIH AA Registry. We collected DNA from a total of 22
multiplex AA pedigrees, comprising 69 unaffected and 78
affected family members. We performed a genome-wide
scan using a panel of 324 microsatellite markers, with an
average marker spacing of 10 cM in all DNA samples.
Because of the complex nature of traits, it is expected
that a number of genetic components will be contributing to
the final presentation of the phenotype. For this reason, we
subjected the dataset derived from the genome-wide scan
to a combination of different statistical tests (Terwilliger and
Ott, 1994): (i) the heterogeneity LOD score, maximized over
four settings of the penetrance parameters (MAXHLOD); (ii)
the mean test for affected sib-pairs, as implemented in the
ANALYZE program (ASP); a test of allele sharing that uses
all sibs (ALLSIBS); and a likelihood version of the transmis-
sion disequilibrium test (TDT-LIKE). This strategy represents
a combination of parametric or model-based (MAXHLOD)
and non-parametric or model-free (ASP, ALLSIBS, and TDT-
LIKE) tests.
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